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Abstract
Signalling through the Hippo (Hpo) pathway involves a kinase cascade, which leads to the
phosphorylation and inactivation of the pro-growth transcriptional co-activator Yorkie (Yki).
Despite the identification of a large number of pathway members and modulators, our
understanding of the molecular events that lead to activation of Hpo and the downstream
kinase Warts (Wts) remain incomplete. Recently, targeted degradation of several Hpo path-
way components has been demonstrated as a means of regulating pathway activity. In par-
ticular, the stability of scaffold protein Salvador (Sav), which is believed to promote Hpo/Wts
association, is crucially dependent on its binding partner Hpo. In a cell-based RNAi screen
for ubiquitin regulators involved in Sav stability, we identify the HECT domain protein Herc4
(HECT and RLD domain containing E3 ligase) as a Sav E3 ligase. Herc4 expression pro-
motes Sav ubiquitylation and degradation, while Herc4 depletion stabilises Sav. Interest-
ingly, Hpo reduces Sav/Herc4 interaction in a kinase-dependent manner. This suggests the
existence of a positive feedback loop, where Hpo stabilises its own positive regulator by
antagonising Herc4-mediated degradation of Sav.
Introduction
The Hippo (Hpo) pathway has emerged as a major regulator of growth and tissue size [1,2]. It
was originally identified in Drosophila using genetic screens for mutations resulting in tissue
overgrowth [3–12]. The core of the Hpo pathway in Drosophila comprises two kinases, Hpo
andWarts (Wts). Activated Hpo phosphorylates the downstream kinase Wts, which leads to
the Wts-mediated phosphorylation of the transcriptional co-activator Yorkie (Yki) [7,13].
Phosphorylated Yki is sequestered in the cytosol by 14-3-3 proteins, thereby preventing activa-
tion of Yki target genes [14,15]. In the nucleus, Yki associates with a number of transcription
factors, such as the TEA (Transcription enhancer factor) domain-containing protein Scalloped
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(Sd) [16,17], to induce the expression of growth-promoting genes (e.g.myc, bantam and diap1)
[13,18–20]. Hence, inactivation of Yki by Wts inhibits growth through the transcriptional
repression of these pro-growth regulators. The Hpo pathway is highly conserved between
mammals and Drosophila [1,2]. In humans, the Hpo orthologues MST1/2 (Mammalian Sterile
20-like) phosphorylate the Wts orthologues LATS1/2 (Large Tumor Suppressor), leading to
the phosphorylation of the Yki orthologues YAP and TAZ [21–25].
Over the last decade, various genetic screens and proteomic approaches have identified
many new components of the pathway [26]. This has generated a vast amount of information
and increased understanding of the molecular mechanisms involved in the regulation of this
pathway, leading to the notion that Hpo signalling acts as a sensor for mechanical cues, apico-
basal and planar polarity and G-protein coupled receptors [1,2,21,27,28]. Thus, Hpo signalling
is a key effector of tissue architecture in growth control.
However, despite the ever-expanding complexity of Hpo upstream signalling, the regulation
and function of the core components still remain incompletely understood. In particular, apart
from phosphorylation, the role of covalent protein modifications, such as ubiquitylation and
SUMOylation has been little explored. One well-characterised instance is the regulation of the
Yki orthologs YAP and TAZ by the SCFSlimb/β-TrCP E3 ligase complex [29,30]. Sequential phos-
phorylation of a YAP/TAZ phospho-degron by Casein Kinase 1@/ε and LATS1/2 leads to rec-
ognition and degradation by SCFSlimb/β-TrCP. Moreover, several other components of the Hpo
pathway have been reported to be targets of ubiquitin-dependent proteasomal degradation,
such as RASSF1A, RASSF5/NORE1, Mob1 andWts/LATS1 [31–36].
The present study focuses on the tumor suppressor protein Salvador (Sav), which, together
with Hpo andWts, was one of the first Hpo pathway components to be identified [5,6]. Sav is a
WW domain-containing scaffold protein, which interacts with the Hpo kinase via their C-ter-
minal SARAH (Salvador, RASSF, Hippo) domains [5,6,37]. The functional importance of Sav/
Hpo dimerisation for Hpo kinase activity remains unclear, since Hpo/MST dimerisation is suf-
ficient to promote activation by trans-phosphorylation [38–40]. However, genetic evidence in
flies and vertebrates clearly indicates that Sav is required for Hpo pathway activity. For
instance, loss of fly sav phenocopies the overgrowth phenotype of hpomutants [5,6,41,42],
while knockout mice for WW45/Sav1 display YAP-dependent phenotypes in multiple tissues
[9,41–43]. Recent work indicates that Sav promotes membrane recruitment of Hpo, where it
can phosphorylate and activate Wts [44]. Another clear consequence of Sav/Hpo dimerization
is the phosphorylation and stabilization of Sav, both in flies and mammals [7,9,45,46]. How-
ever, it is not clear whether Sav phosphorylation by Hpo is responsible for its stabilization,
since a point mutant in the ATP-binding pocket (Lysine to Arginine, K/R) of Hpo/MST still
stabilizes Sav [9,45]. Here, we use an RNAi screening approach to identify regulators of Sav sta-
bility. We identify the HECT E3 ubiquitin ligase Herc4 as a negative modulator of Hpo signal-
ling. In addition, we show that Hpo can stabilise Sav by interfering with Herc4-dependent Sav
degradation.
Material and Methods
Drosophila cell culture and expression constructs
Drosophila S2 cells were transfected with Effectene transfection reagent (Qiagen) and grown in
Drosophila Schneider’s medium (Life Technologies) containing 10% FBS (Sigma), 50μg/ml
penicillin and 50 μg/ml streptomycin. Expression plasmids were generated using Gateway1
technology (Life Technologies). Open reading frames (ORF) were PCR amplified from existing
plasmids or cDNA (DGRC, https://dgrc.cgb.indiana.edu/vectors/) and cloned into Entry vec-
tors (pENTRTM/D-TOPO). Vectors from the Drosophila Gateway Vector Collection (http://
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www.ciwemb.edu/labs/murphy/Gateway%20vectors.html) were used as Destination vectors.
All expression plasmids were sequence-verified. Point mutations were generated using the
Quikchange1Multi Site-Directed Mutagenesis Kit (Stratagene).
dsRNA production and treatment
RNAi library generation work-plan can be found in the supplementary figures (S2–S4 Figs).
dsRNAs were synthesized using the Megascript T7 kit (Ambion). DNA templates for dsRNA
synthesis were PCR-amplified from genomic DNA using primers that contained the 5’ T7
RNA polymerase-binding site sequence. dsRNA primers were designed using the DKFZ RNAi
design tool (http://www.dkfz.de/signaling2/e-rnai/)
RNAi screening was carried out as outlined in S3 Fig. Follow-up RNAi experiments were
carried out in 6 well plates using S2 cells. 1-2x106 cells were plated per well and cells left to set-
tle. After 3 h the medium was removed and replaced with 1 ml of serum free Schneider’s
medium containing dsRNAs (20 μg). Cells were soaked for 30 min and then 2 ml of full Schnei-
der’s medium was added. Transfections were carried out 24 h after dsRNA treatment.
Immunoprecipitation and immunoblot analysis
For immunoprecipitation assays, cells were lysed in Lysis Buffer (50 mM Tris pH8, 150 mM
NaCl, 1% NP-40, and 1 mM EGTA) supplemented with 0.1M NaF, phosphatase inhibitor
cocktails 2 and 3 (Sigma) and protease inhibitor cocktail (Roche). Cell extracts were cleared at
16,000 g for 20 min at 4°C. FLAG-tagged proteins were purified using anti-FLAGM2 Affinity
Agarose Gel (Sigma), whereas immunoprecipitation of Myc-tagged proteins was carried out
using Protein A Sepharose (Sigma). Detection of purified proteins and associated complexes
was performed by immunoblot analysis using chemiluminescence (Pierce). Western Blots were
probed with mouse anti-FLAG (M2, Sigma), rabbit anti-FLAG (Sigma), mouse anti-Myc
(9E10, Santa Cruz Biotechnology), rabbit anti-Myc (Santa Cruz Biotechnology), rat anti-HA
(3F10, Roche Applied Science), mouse anti-Tubulin (E7, Developmental Studies Hybridoma
Bank, DSHB) and mouse anti-GFP (in-house produced), rat anti-Yki [47], and rabbit [48] and
guinea pig anti Sav (a kind gift from G. Halder).
Ubiquitylation assays
For ubiquitylation assays S2 cells were transfected with Myc-Sav and HA-Ubiquitin and, unless
otherwise stated, treated with proteasome inhibitors for 4 h. Cells were harvested and lysed in
Lysis buffer (see above). Lysates were immunoprecipitated with an anti-Myc antibody and Pro-
tein A Sepharose (Sigma), and subjected to western blot analysis. Ubiquitylation was detected
using an antibody against HA-Ubiquitin. Lysis buffer containing 5mMN-Ethylmaleimide
(NEM) (Sigma) was used to block deubiquitylating enzyme activity.
Proteasome inhibitor treatment
For proteasome inhibition experiments, cells were treated with 50μMMG132 (Calbiochem)
and 50μM calpain inhibitor I (Ac-LLnL-CHO or LLnL) (Sigma) for 4 h before cell lysis. Ubi-
quitylation assays were carried out after proteasome inhibitor treatment, unless stated
otherwise.
Western blot analysis of fly heads
Heads were cut off from frozen animals and lysed in RIPA buffer (10 mM Tris HCl pH 7.5, 150
mMNaCl, 1% (v/v) Triton X-100, 0.1% (w/v) SDS, 1% (w/v) Sodium deoxycholate)
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supplemented with 0.1M NaF, phosphatase inhibitor cocktails 2 and 3 (Sigma) and protease
inhibitor cocktail (Roche). Tissue lysates were incubated on ice for 10 min and subsequently
cleared by centrifugation at 16,000 g for 10 min at 4°C. 150ug of total lysate was loaded per
lane.
Immunofluorescence
Wing imaginal discs from third-instar larvae were dissected, fixed for 20 min in 4% formalde-
hyde, washed three times in PBS supplemented with 0.1% Triton X-100 (PBS-T) and pre-
blocked in PBS supplemented with 0.3% Triton X-100 and 10% normal goat serum (NGS) for
1 h. Discs were incubated overnight in the primary antibody diluted in PBS-T containing 10%
NGS, followed by three washes with PBS-T, and incubation with a secondary antibody in
PBS-T/10% NGS for 2 h at room temperature. After three further washes, discs were mounted
in Vectashield mounting medium with DAPI (Vectorlabs). Rat anti-Ci155 antibody (Develop-
mental Studies Hybridoma Bank, monoclonal 2A1) was used at 1:20. Secondary anti-rat Alexa
647 antibody (Molecular Probes) was used at 1:200. Fluorescence images were acquired on a
Zeiss LSM710 confocal laser scanning microscope (40x objective lens).
Sequence Alignments
Multiple sequence alignment and phylogenetic tree analysis was carried out using Clustal
Omega (EMBL-EBI). Protein sequence accession numbers were as follows: Itch hs BAB39389.1
(GenBank), Nedd4 hs AAI44285 (AAI44285), Smurf1 hs EAL23885 (EAL23885), Herc1 hs
Q15751.2 (UniProtKB/Swiss-Prot), Herc2 hsO95714.2 (UniProtKB/Swiss-Prot), Herc3 hs
Q15034.1 (UniProtKB/Swiss-Prot), Herc4 hsQ5GLZ8.1 (UniProtKB/Swiss-Prot), Herc5 hs
Q9UII4.2 (UniProtKB/Swiss-Prot), Herc6 hs Q8IVU3.2 (UniProtKB/Swiss-Prot), Herc4 dm
(CG9153) Q5GLZ8.1 (UniProtKB/Swiss-Prot).
Generation of herc4 CRISPRmutant
Introduction of a frame-shift mutation in the herc4 gene was performed using the CRISPR/
Cas9 system [49]. Suitable target sites for guide RNAs (sgRNA) were determined using http://
www.flyrnai.org/crispr/. Sense and anti-sense oligos of the selected sgRNA were annealed,
phosphorylated and cloned into the expression vector pCFD3 according to the protocol
described on http://www.crisprflydesign.org/grna-expression-vectors/. DNA was injected into
embryos of y1,M{nos-Cas9.P}ZH-2A w transgenic flies (Bloomington stock number 54591)
by the Fly Facility at the University of Cambridge Department of Genetics. G0 flies were then
crossed with the w;;TM3/TM6 balancer strain; subsequently, G1 male flies were crossed with
the same balancer strain, followed by genomic DNA screening for frame-shift mutations. We
also balanced a wild type progeny of the injected founders to use as a control strain (herc4ctrl).
Analysis of Drosophila adult wings
Adult wings were mounted using Euparal mounting medium (Agar Scientific) and imaged
using a Zeiss Axio-plan 2 imaging system, using Optovar optics (1.6x) and a 2.5x objective
(Plan-NEOFLUAR, Zeiss) connected to a Leica DFC420C camera. Wings were subsequently
measured and quantified using ImageJ.
Genotypes
Fig 6: left panels: w; ubi-GFP::sav/+; hh-GAL4/+, right panels: w; ubi-GFP::sav/+; hh-GAL4/
UAS-Herc4.
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Fig 10: w; UAS-CD8-GFP; rn-GAL4. w; UAS-herc4; rn-GAL4., w; UAS-herc4-C/A; rn-GAL4.
w; UAS-CD8-GFP; rn-GAL4, UAS-sav. w; UAS-herc4; rn-GAL4, UAS-sav. w; UAS-herc4-C/A;
rn-GAL4, UAS-sav. w; UAS-CD8-GFP; rn-GAL4, UAS-sav-S413A. w; UAS-sav-S413A; rn-
GAL4, UAS-herc4. w; UAS-herc4-C/A; rn-GAL4, UAS-sav-S413A.
Fig 11: w;; rn-GAL4/ctrl. w;; rn-GAL4, UAS-sav/ctrl. w;; rn-GAL4, UAS-sav-S413A/ctrl. w;;
rn-GAL4/herc4C6.3. w;; rn-GAL4, UAS-sav/ herc4C6.3. w;; rn-GAL4, UAS-sav-S413A/ herc4C6.3.
Results
Sav is ubiquitylated and degraded by the proteasome
Sav is an unstable protein and its stability is regulated by the proteasome system (Fig 1A,
[7,9,45,46]). As proteasomal degradation is triggered by poly-ubiquitylation of target proteins,
we performed a cell-based ubiquitylation assay by co-expressing Myc-tagged Sav with HA-
tagged ubiquitin, followed by Myc immunoprecipitation (Fig 1A). This revealed the presence
of Sav poly-ubiquitylated species, which were stabilised by treatment with proteasome inhibi-
tors. Ubiquitin conjugation primarily occurs through the formation of an isopeptide bond
between the ubiquitin C-terminus and the epsilon amino group of lysine residues on the sub-
strate [50]. Sav contains eighteen lysine residues, clustered at both termini of the protein, ten
are contained within amino acids 12 to 57 and eight are located in the area containing the con-
served WW and SARAH domains (Fig 1B). To establish the domain where Sav ubiquitylation
occurs, we analysed Sav truncations spanning either the N or C terminal part of the protein
(SavΔC and SavΔN). As shown in Fig 1B, Sav ubiquitylation occurs within the conserved C-ter-
minal domain, comprising the WW and SARAH domain.
Hpo stabilises Sav by inhibiting its ubiquitylation
We and others have observed that exogenous Sav is stabilised by Hpo co-expression, while
Hpo depletion causes endogenous Sav downregulation (Fig 2A and 2B, [7,9,45,46,48]). In
order to further investigate the role of Hpo in regulating Sav stability, we carried out
Fig 1. Sav is ubiquitylated predominantly in the C-term half of the protein. (A) Sav is stabilised and
shows increased ubiquitylation in the presence of proteasome inhibitors (MG132 and LLnL). Myc-tagged Sav
was expressed in S2 cells with either Ub-HA or ß-Galactosidase (β-Gal) in the presence of proteasome
inhibitors (MG132 and LLnL, M/L) or DMSO control. Sav ubiquitylation assay shows incorporation of HA-
tagged ubiquitin. (B) Left panel: Sav ubiquitylation occurs in the C-terminal half of the protein. Sav deletions
(ΔC and ΔN) were tested for ubiquitylation as described above. Right panel: schematic representation of Sav
protein structure and distribution of Lysine residues. Sav contains eighteen Lysine residues (K), which could
serve as potential ubiquitylation sites: ten are located near the N-terminal end of the protein, whereas the
remaining eight are located in the C-terminus.
doi:10.1371/journal.pone.0131113.g001
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ubiquitylation assays using full-length Sav or Sav truncations (SavΔC and SavΔN) in the pres-
ence or absence of Hpo. Co-expression of Hpo resulted in a reduction in Sav ubiquitylated spe-
cies (Fig 2C), indicating that Hpo regulates Sav stability by preventing its ubiquitylation.
Since Sav ubiquitylation occurs in the C-terminal domain responsible for Hpo binding, Hpo
could sterically interfere with ubiquitin ligase binding or ubiquitin transfer. Alternatively, since
Hpo is known to phosphorylate Sav ([7,9,45,46,51] and this report), phosphorylation might
prevent ligase binding or ubiquitylation. To investigate these possible mechanisms, we analysed
the effect of several Hpo truncations and mutants on Sav ubiquitylation (Fig 3A). Hpo con-
structs that bind but fail to phosphorylate Sav, either by deletion of the kinase domain
(HpoΔN) or point mutation in the T-loop domain (at residue 195 –HpoT195A), were unable
to prevent Sav ubiquitylation (Fig 3B). Similarly, we tested two C-terminal truncations of Hpo
lacking the SARAH domain but still containing the Hpo PPxY motif, the longer of which still
binds Hpo robustly (HpoΔC2), while the shorter truncation is reduced in its ability to bind
Hpo (HpoΔC3), as well as a version of HpoΔC3 carrying a mutation in the PPxY motif
(HpoΔC3/Y591G) motif, which cannot bind Sav at all (Fig 3C). These experiments showed
that the strength of Hpo/Sav binding correlates with the effect of Hpo on Sav ubiquitylation,
with HpoΔC2 strongly blocking Sav ubiquitylation, and HpoΔC3 and HpoΔC3/Y591G having
increasingly weaker effects (Fig 3C). These results indicate that Hpo requires both Sav binding
and kinase activity to inhibit Sav ubiquitylation, thereby excluding steric interference as the
sole mechanism for Hpo action.
Fig 2. Hpo stabilises Sav by inhibiting Sav ubiquitylation. (A) Sav is stabilised when co-expressed with
Hpo. Baseline Sav expression is increased upon proteasome inhibitor treatment (M/L). (B) hpo depletion by
RNAi destabilises Sav protein levels. Top panel: endogenous Sav levels (arrow) in non-transfected S2 cells.
Asterisk indicates a non-specific band detected by the anti-Sav antibody. Bottom panel: levels of transfected
Myc-tagged Sav. Sav depletion by RNAi is used as a control. (C) Hpo inhibits ubiquitylation of Sav. Sav,
SavΔN, and SavΔC were analysed for ubiquitylation in the presence or absence of co-expressed Hpo. Hpo
prevents ubiquitylation of full-length Sav and SavΔN, while SavΔC is not ubiquitylated. (A-C) S2 cells were
transfected with the indicated plasmids or treated with the indicated dsRNAs prior to lysis. Lysates were
processed for western blot analysis or used in co-IP.
doi:10.1371/journal.pone.0131113.g002
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A ubiquitin ligase RNAi screen identifies Herc4 as a Sav E3 ligase
To identify proteins responsible for Sav ubiquitylation, we carried out a cell-based RNAi screen
using a Drosophila dsRNA sub-library containing known and candidate genes involved in ubi-
quitylation (378 genes involved in ubiquitin conjugation and ubiquitin binding). The effect of
dsRNAs on Sav-Myc expression was analyzed by standard Western-blot analysis. Using this
approach we identified the HECT domain protein Herc4 (CG9153) as a Sav E3 ligase (Fig 4A).
Drosophila Herc4 contains a RLD (RCC1-like domains) domain comprising 7 RCC1-like
repeats and a HECT domain [52] (Fig 4B). RLD domains are structural scaffolds with a β-pro-
peller architecture believed to be involved in protein-protein interactions, whereas the HECT
domain is a conserved E3 ligase domain [53,54]. HECT domains bind specific ubiquitin-conju-
gating enzymes (E2s), accept ubiquitin from the E2 to form a ubiquitin-thioester intermediate
with the HECT active cysteine (Fig 4B), then transfer ubiquitin to the substrate. Herc4 belongs
to the subfamily of small Herc E3 ligases, which in humans comprises 4 members, Herc3-6
[52]. In Drosophila there are only 2 small Herc E3 ligases, Herc2 and Herc4. Drosophila Herc4
is marginally more related to human Herc4 than human Herc3 (45% and 44% identity between
CG9153 and hsHerc4 and hsHerc3, respectively; Fig 4C).
Herc4 controls Sav stability and ubiquitylation in vitro and in vivo
HECT E3 ligases physically interact with their substrates [54]. To determine whether Herc4
associates with Sav, we performed co-immunoprecipitation (co-IP) experiments in S2 cells
using tagged Herc4 and Sav. Herc4 robustly associated with Sav, but not with a control protein,
Rep3 (Fig 5A). We identified Herc4 based on the ability of herc4 RNAi to increase Sav protein
levels in S2 cells (Fig 5B). To further investigate the functional significance of this finding, the
Fig 3. Binding of active Hpo to Sav is required to inhibit Sav ubiquitylation. (A) Schematic
representation of Hpo constructs used. Protein domains and point mutations in the Hpo T-loop inactivating
Hpo kinase (HpoT195A) and PPxYmotif (Y591G) are indicated. (B) Sav ubiquitylation assays with co-
expressed Hpo truncations (HpoΔN and ΔC) or Hpo kinase dead (HpoT195A). While full-length Hpo prevents
Sav ubiquitylation, truncations lacking the kinase domain or C-terminus, or a kinase-dead Hpo have no effect.
(C) Hpo C-terminal deletions (HpoΔC2 and HpoΔC3) and a Hpo C-terminal deletion mutated for the PPxY
motif (HpoΔC3/Y591G) affect Sav ubiquitylation proportionally to their ability to bind Sav (compare upper and
lower panels).
doi:10.1371/journal.pone.0131113.g003
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role of Herc4 in Sav ubiquitylation was analysed. We performed a cell-based ubiquitylation
assay in the presence of the deubiquitylating enzyme inhibitor NEM to preserve ubiquitylated
species. As shown in Fig 5C, herc4 RNAi resulted in a marked reduction of Sav ubiquitylation
compared to control RNAi treatment, indicating that Herc4 is required for Sav ubiquitylation.
To assess the specificity of Herc4 as a Sav E3 ligase, we analyzed the effect of Herc4 overex-
pression on Sav ubiquitylation. Expression of Herc4 enhanced Sav ubiquitylation and reduced
Sav protein levels in cell lysates, while a catalytically impaired Cysteine to Alanine mutant
(Herc4C/A) had a reduced effect (Fig 5D). In agreement with our previous observations (Fig
1B), the C-terminal portion of Sav (SavΔN), but not the N-terminal (SavΔC), binds to and is
ubiquitylated by Herc4 (Fig 5D). In contrast, two other HECT domain E3 ligases, Su(dx) and
Nedd4, did not promote Sav ubiquitylation (S1 Fig).
Next, we explored the effect of Herc4 on Sav stability in vivo. We generated a GFP-tagged
sav transgene, expressed under the control of the ubiquitin promoter (ubi-GFP::sav). Using the
GAL4/UAS system, UAS-Herc4 was expressed in the posterior compartment of wing imaginal
discs, the larval precursor to the adult wing, using the hh-Gal4 (referred to as hh>herc4) driver.
Cubitus interruptus (Ci) staining was used to differentiate the anterior (Ci-positive) and poste-
rior (Ci-negative) compartments of the wing imaginal disc. Herc4 overexpression caused
depletion of Sav levels (Fig 6, right panels), indicated by the reduction in the GFP signal. These
results are consistent with our biochemical data showing that Herc4 promotes Sav ubiquityla-
tion and proteasomal degradation.
Mapping the Herc4/Sav interaction domains
To map the domains required for the interaction between Herc4 and Sav, we carried out co-IP
experiments using fragments of either protein (Fig 7). Using this strategy, we were able to map
Fig 4. Ubiquitin ligase RNAi screen identifies Herc4 as a Sav E3 ligase. (A) E3 RNAi screen work-plan
(B) Diagram depicting the Herc4 protein domain structure and alignment of HECT domains. Herc4 contains
seven RCC1 repeats and a HECT E3 ligase domain. Protein alignment shows the last 36 aa of Drosophila
melanogaster Herc4 aligned with the corresponding sequences of human Nedd4, Itch, Smurf, and Herc3.
The conserved catalytic cysteine is shown in red. (C) Phylogenetic tree of human Herc1-6 and Drosophila
melanogaster Herc4.
doi:10.1371/journal.pone.0131113.g004
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the Herc4 interaction domain to the RLD domain as deleting the whole RLD abolishes binding
between the two proteins. Deletion of RCC1-like repeats 1–3 had no effect on binding, neither
did deletion of the entire HECT domain (Fig 7A). Thus, Herc4 binds Sav via RCC1-like
domains 4–7.
Herc4 binds to the conserved C-terminus of the Sav protein (Fig 5D). To precisely define
the region responsible for Sav/Herc4 binding, we analysed C-terminal fragments of Sav in co-
IP experiments with Herc4 (Fig 7B). The domain responsible for the association of Herc4 to
Sav can be narrowed down to the region stretching from the end of the WW domains to the
beginning of the SARAH domain (aa 492–546), as deleting this domain abolishes binding
between Herc4 and Sav (Fig 7B). Adding the SARAH domain (SavΔN4) renders the interaction
Fig 5. Herc4 controls Sav stability and ubiquitylation. (A) Sav binds to Herc4. Myc-tagged Sav was
immunoprecipitated using a Myc antibody and bound Herc4-Flag protein detected using Flag antibody. Myc-
taggedDrosophilaRep3 was used as control. (B) herc4RNAi stabilises Sav protein levels. Left panel:
endogenous Sav levels (arrow) in non-transfected S2 cells. Asterisk indicates a non-specific band detected
by the anti-Sav antibody. Left bottom panel: quantification presented as ratio of Sav/Tub levels. Right panel:
levels of transfected Myc-tagged Sav. Right bottom panel: quantification presented as ratio of Sav-Myc/Tub
levels (C) herc4 RNAi reduces Sav ubiquitylation. Sav ubiquitylation assay of Myc-tagged Sav expressed in
S2 cells, treated with dsRed RNAi, herc4RNAi or savRNAi. Ubiquitylation assay was performed in the
presence of 5mMNEM to block deubiquitylating enzyme activity (D) Overexpression of Herc4 results in
destabilisation and increased ubiquitylation of Sav, which is dependent on the active site cysteine. Sav
ubiquitylation assay of Myc-tagged Sav, SavΔN and SavΔC co-expressing either Flag-Herc4 or Flag-
Herc4C/A.
doi:10.1371/journal.pone.0131113.g005
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more robust, and elicits the appearance of a ladder of higher molecular species, which could
indicate poly-ubiquitylation (Fig 7B).
Antagonism between Herc4 and Hpo determines Sav stability
As both Herc4 and Hpo have a role in regulating Sav ubiquitylation and stability, we tested a
possible functional interaction between the two proteins. Combined expression of Hpo and
Herc4 resulted in reduced Herc4-induced Sav ubiquitylation (Fig 8A). We also noted that
upon Hpo co-expression there was reduced association between Herc4 and Sav (Fig 8A). Simi-
larly, Hpo reduced Sav levels in Herc4 immunoprecipitates (Fig 8B). Interestingly, the kinase
dead version of Hpo (HpoT195A) did not affect Sav/Herc4 binding (Fig 8B), indicating that
the effect of Hpo is phosphorylation-dependent. These results suggest that phosphorylation of
Sav by Hpo prevents Herc4/Sav binding, leading to Sav stabilization. Depletion of hpo causes
Sav to be destabilized (Fig 2B), suggesting that under those conditions Sav is no longer
Fig 6. Herc4 overexpression reduces Sav protein levels in vivo.GFP-tagged Sav was expressed under
the control of the ubiquitin promoter (ubi-GFP::Sav) and analysed in 3rd instar larval wing discs expressing
hh-GAL4 alone (left panel) or UAS-herc4 in the posterior compartment (hh>herc4). White dotted lines denote
the border between the anterior and posterior compartments of the wing. Anti-Ci staining marks the anterior
compartment. Scale bar = 100μm.
doi:10.1371/journal.pone.0131113.g006
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protected from Herc4-mediated degradation. Indeed, co-depletion of herc4 and hpo restored
Sav levels (Fig 8C). Thus, the interplay between Hpo and Herc4 determines Sav stability.
herc4 depletion prevents Sav destabilization caused by loss of apical
Hpo pathway regulators
Recent reports have highlighted the importance of the cell cortex as an organising centre for
Hpo pathway activity [44,47,55–58]. Several apically localized proteins, such as the Kibra/
Expanded/Merlin (KEM) complex and the immunoglobulin super-family trans-membrane
protein Echinoid (Ed), have been proposed to recruit Hpo/Sav to the cell membrane. In partic-
ular, Ed has been shown to bind Sav and prevent its degradation [55].
Expression of Ed and Kibra in S2 cells stabilises co-transfected Sav (Fig 9A and [55]). Con-
versely, loss of either Kibra or Ed causes a marked reduction of Sav levels (Fig 9B and 9C), sug-
gesting that loss of apical tethering of Sav makes it a target for ubiquitylation and degradation.
To investigate this assumption further, we tested the effect of depleting herc4 in this context. S2
cells were transfected with Sav-Myc and treated with dsRNA for kibra and ed in combination
with herc4 RNAi or lacZ RNAi as a control. herc4 RNAi rescued the destabilising effect of ed
and kibra RNAi (Fig 9B and 9C). Thus, when apical members of the Hpo pathway are depleted,
Sav is released into the cytosol, where Herc4 promotes its ubiquitylation and subsequent degra-
dation by the proteasome.
Growth regulatory function of Herc4
One of the main effects of Hpo pathway disruption in vivo is an increase in tissue size. To
investigate the impact of Herc4 on tissue growth control via Sav, we combined GAL4/UAS-
driven Herc4 expression with transgenic lines expressing either wild type Sav or a version
which is refractory to inhibition by the Salt-Inducible Kinases (Sik2/3) and therefore more
active (SavS413A) [59]. The transgenes were expressed under the control of the wing-specific
Fig 7. Mapping of Herc4/Sav binding. (A) Mapping of Herc4 interaction domain with Sav. Co-IPs of Sav
with Herc4 truncations lacking the N-terminal RCC1 domains (ΔRCC1-3, ΔRCC1-7) or the HECT domain
(ΔHECT). The RCC4-7 repeats are required for binding of Herc4 to Sav. (B) Mapping of the Sav interaction
domain with Herc4. C-terminal fragments of Sav were used in co-immunoprecipitation experiments with
Herc4. (C) Schematic representation of Herc4 and Sav truncations used in A and B.
doi:10.1371/journal.pone.0131113.g007
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driver rotund-Gal4 (rn-Gal4). Overexpression of wild type Sav modestly reduced the size of the
wing, while the SavS413A mutant had a stronger effect (Fig 10A). Expression of UAS-herc4 was
sufficient to partially suppress the undergrowth phenotype caused by Sav overexpression. This
effect was dependent on the E3 ligase activity of Herc4, since overexpression of a HECT mutant
version of Herc4 (UAS-Herc4C/A) had no effect on wing size (Fig 10A and 10B). Thus, Herc4
expression is able to suppress Sav growth-inhibitory function in vivo.
To study the effect of loss of Herc4 activity we generated a herc4mutant using CRISPR tech-
nology [49]. Using an sgRNA that targets the second exon of herc4, we generated a mutation,
herc4C6.3, carrying a one base-pair deletion at codon position C92 (cysteine 92) (Fig 11A). This
mutation induces a frame-shift resulting in the production of a 30aa peptide (followed by 24aa
of out-of-frame sequence), which lacks most of the Herc4 protein (Fig 11B). Homozygous
herc4C6.3mutant animals were viable and fertile and had no apparent morphological abnormal-
ities. This is not surprising, as modest overexpression of Sav, for instance in the eye under the
GMR promoter, does not lead to a visible phenotype [5]. We therefore tested whether herc4C6.3
could modify the undergrowth phenotype elicited by strong overexpression of Sav in the wing
under the rn-GAL4 driver (Fig 11C and 11D). Interestingly, loss of herc4C6.3 does not modify
the undergrowth induced by savS413A, which is already an activated form. By contrast, the
herc4C6.3 mutant significantly enhanced the undergrowth induced by wild type Sav
overexpression.
Fig 8. Hpo competes with Herc4 for Sav binding and antagonises Herc4-mediated ubiquitylation of
Sav. (A) Hpo reduces Herc4-induced ubiquitylation of Sav. Sav ubiquitylation assay was performed using
Myc-tagged Sav co-expressed with either Hpo, Herc4 or Hpo and Herc4 combined. Ubiquitylation assay was
performed in the presence of 5mMNEM to block deubiquitylating enzyme activity. (B) Binding of Sav to
Herc4 is prevented by active Hpo kinase (compare left with right lane), while kinase-dead Hpo has no effect
(compare left and middle lanes). Herc4/Sav co-IP experiments were performed in the presence of a control
protein (GFP), wild-type or kinase dead version of Hpo (HpoT195A). (C) herc4RNAi rescues the
destabilizing effect of hpo RNAi on Sav protein levels. S2 cells expressing Myc-tagged Sav (and GFP-Flag as
a control) were treated with the indicated combinations of dsRNA.
doi:10.1371/journal.pone.0131113.g008
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To test whether loss of herc4 affects Sav protein levels in vivo, we analysed Sav protein levels
in fly heads by Western blot. Fig 11E shows that Sav protein levels were increased in herc4C6.3
heads compared to control heads. Together, these results support a role for Herc4 as a Sav E3
ligase.
Discussion
The scaffold protein Sav is a core component of the Hpo signalling pathway and its genetic
inactivation is sufficient to increase tissue growth in flies and mice [5,6,41,43]. Sav dimerises
with Hpo through their respective SARAH domains [7–11], and recruits Hpo to the plasma
membrane, thereby promoting Wts phosphorylation [44]. In addition, Sav associates with the
downstream kinase Wts via a WW domain/PPxY interaction [5]. Sav may therefore scaffold
the Hpo/Wts core kinase cassette, thereby further strengthening Wts phosphorylation and acti-
vation. Indeed, mammalian Sav1/WW45 immunoprecipitates with endogenous Lats1 and
Mst2 [21], and Sav strengthens the Hpo/Wts association in Drosophila tissue culture cells [59].
Sav levels appear to be tightly regulated by proteasomal degradation, and its association
with Hpo/MST promotes both its phosphorylation and stabilisation ([7,9,45,46], this report).
Using a point mutation in the ATP-binding pocket (Lysine to Arginine, K/R), we and others
Fig 9. herc4 depletion prevents the decrease in Sav protein levels elicited by loss of apical Hpo
pathway regulators. (A) Co-expression of Ed and Kibra stabilizes Myc-tagged Sav. Hpo co-transfection is
used as a positive control. (B) herc4RNAi rescues ed RNAi-induced reduction in Sav protein levels. (C)
herc4RNAi rescues kibra RNAi-induced reduction in Sav protein levels. (A-C) S2 cells were transfected with
Sav-Myc and the indicated plasmids, and treated with the indicated dsRNAs before lysis and western blot
analysis.
doi:10.1371/journal.pone.0131113.g009
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had observed that Hpo/MST kinase activity appeared dispensable for Sav stabilisation, opening
the possibility for the involvement of another kinase [9,45]. However, since a version of Hpo
carrying a mutation in the T-loop (T195A) and a truncation lacking the kinase domain both
fail to phosphorylate and stabilise Sav (Fig 3), it seems most likely that Hpo kinase activity is in
fact responsible for stabilising Sav, suggesting that the HpoK/R mutant has residual activity.
In order to shed light on the regulation of Sav stability, we performed a screen for Sav E3
ligases, leading us to identify Herc4 as a negative regulator of Sav (Fig 4). We show that herc4
depletion reduces Sav ubiquitylation in cell culture (Fig 5) and that herc4mutants have elevated
Sav levels in vivo (Fig 11). However, since the increase in Sav levels in herc4mutants are rela-
tively modest, it is possible that other Sav ubiquitin ligases operate in parallel to Herc4. The
Herc family is a poorly characterised group of six proteins containing a C-terminal HECT ubi-
quitin ligase domain and at least one N-terminal RLD [52]. Mammalian Herc1 and 2 are large
(~500 KDa) proteins containing multiple RLDs as well as other domains (WD40, zinc fingers),
while Herc3-6 have shorter N-termini containing one RLD domain. As a β-propeller structure,
the RLD domain is likely to constitute a substrate-recruitment motif [53]. Indeed, we showed
that Sav binding requires RCC1 repeats 4–7 (Fig 7). Drosophila has a single Herc1/2 ortholog
(called Herc2) and a single Herc3-6 ortholog (CG9153, which we name Herc4 based on
sequence homology). Herc4 mutant mice are viable but males display a spermatozoon matura-
tion defect [60]. In addition, Herc4 was found to be upregulated in over half of a cohort of inva-
sive ductal breast carcinoma [61]. It would therefore be interesting to examine Sav1/WW45
levels in these tumours, as well as assess their differentiation status, since recent work shows
that Sav is required for terminal differentiation in the mouse breast epithelium [42].
In this report, we have also shown that the ability of Herc4 to degrade Sav is antagonised by
Hpo (Fig 8). Furthermore, Hpo co-expression is able to displace Herc4 from Sav in a kinase
domain-dependent manner. This could be due to phosphorylation by Hpo of the interaction
Fig 10. Growth regulatory function of Herc4. (A) Overexpression of Herc4 leads to a partial rescue of the
Sav overexpression phenotype. Expression of sav (rn>sav) and savS413A (rn>savS413A) transgenes under
the control of the rotund (rn) promoter causes tissue undergrowth and results in smaller wings. Both
transgenes were combined with eitherUAS-herc4, UAS-herc4C/A or UAS-CD8-GFP to address the effect of
Herc4. (B) Quantification of wing sizes. Shown are fold changes of average wing areas for the indicated
genotypes compared to the control (rn>UAS-CD8-GFP), which was set as 1. Statistical significance
assessed by Student’s t-test. * p < 0.0001. N.S. p > 0.05. n = 10–21. Error bars denote standard deviations.
doi:10.1371/journal.pone.0131113.g010
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Fig 11. Generation and in vivo analysis of herc4C6.3mutant. (A) Sequence analysis of herc4CRISPR
mutation. Sequence chromatogram of the sgRNA target sequence (boxed in the sequence alignment on the
right) showing the loss of cytosine 92 (C92) in the herc4C6.3 strain (marked by asterisk). (B) Diagram and
sequence of the predicted protein resulting from frame-shift mutation. The loss of C92 results in a frame-shift
mutation and a truncated protein of 30aa plus 24aa of out-of-frame sequence. (C) herc4C6.3 enhances the
Sav overexpression phenotype in the wing. Both sav (rn>sav) and savS413A (rn>savS413A) transgenes were
combined with heterozygosity for either herc4C6.3 or herc4ctrl and wings sizes were analysed. (D)
Quantification of wing sizes. Shown are fold changes of average wing areas for the indicated genotypes
compared to the control (rn/ctrl), which was set as 1. Statistical significance assessed by Student’s t-test.
* p < 0.0001. N.S. p > 0.05. n = 10–21. Error bars denote standard deviations. (E) Levels of Sav protein in fly
heads of herc4C6.3, herc4ctrl andGMR>savS413Awere analysed byWestern blot. Bottom panel:
quantification presented as ratio of Sav/Yki levels from three independent repeats. * p = 0.0385 with a
Student’s t-test.
doi:10.1371/journal.pone.0131113.g011
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surface on either Sav or Herc4. Our data are consistent with a model in which apical recruit-
ment of Sav by proteins such as Ed and the KEM complex can stabilise Sav, perhaps by bring-
ing it in close proximity to active Hpo at the plasma membrane. This would lead to
stabilisation of Sav, promote Wts activation by Hpo and, ultimately, lead to Yki inhibition. We
therefore propose that Hpo can strengthen the activation of the Hpo pathway core kinase cas-
sette by phosphorylating its own adaptor Sav, thereby preserving it from Herc4-dependent
degradation.
Supporting Information
S1 Fig. The Hect E3 ligases, Su(dx) and Nedd4, do not increase Sav ubiquitylation. Flag-
tagged Herc4, Su(dx) and Nedd4 were expressed in S2 cells together with Sav-Myc and Ub-
HA. After lysis, Sav was analysed for ubiquitylation.
(TIF)
S2 Fig. RNAi library generation work plan.
(TIF)
S3 Fig. RNAi screen in S2R+ cells.
(TIF)
S4 Fig. Lysis andWestern Blot analysis.
(TIF)
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